3-methyl-1,2,3,4-tetrahydroquinazolin-2-one

CAS No. 24365-65-9

3-methyl-1,2,3,4-tetrahydroquinazolin-2-one( —— )

Catalog No. M28377 CAS No. 24365-65-9

3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
  • Description
    3-methyl-1,2,3,4-tetrahydroquinazolin-2-one is a inhibitor of BRD4 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24365-65-9
  • Formula Weight
    162.192
  • Molecular Formula
    C9H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1Cc2ccccc2NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jian Tang, et al. Antitumor and antiplatelet activity of alkaloids from veratrum dahuricum. Phytother Res. 2010 Jun;24(6):821-6.
molnova catalog
related products
  • 653-47 hydrochloride

    653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15.?

  • dBRD9 HCl

    dBRD9 HCl is a PROTAC composed of the BRD9 inhibitor BI 7273 conjugated to the cereblon E3 ligase ligand pomalidomide . dBRD9 HCl is a potent and selective degrader of BRD9 (IC50 = 56.6 nM in MOLM-13 cells).

  • Pocenbrodib

    Pocenbrodib (FT-7051) is a potent inhibitor of the bromodomain of the CBP/p300 family with potential antitumour activity and is palatable for cancer research.